Department of Pediatric Cardiology, University of Minnesota/Masonic Children's Hospital, Minneapolis, MN 55454, USA.
Department of Pediatric Cardiology, University of Utah, Salt Lake City, UT 84112, USA.
Future Cardiol. 2022 Sep;18(9):679-686. doi: 10.2217/fca-2021-0139. Epub 2022 Aug 17.
In pediatrics, conventional transvenous and epicardial pacemaker systems carry complications, such as lead distortion due to growth and activity, in addition to lead and pocket complications. A retrospective review of pediatric leadless pacing at the University of Minnesota Masonic Children's Hospital (MN, USA) from 2018 through 2021 was performed. Diagnoses, rationale for pacing, demographics, pacing thresholds and longevity of devices were recorded. Twelve leadless pacemaker insertions and one removal were performed successfully in patients weighing 19-90 kg. Six patients had Micra implantation via the internal jugular vein without surgical cut-down. Up to 3 years of follow-up were noted, with median follow-up of 22 months. No late complications occurred. Leadless pacemaker implantation and early retrieval were feasible in pediatric patients.
在儿科领域，传统的经静脉和心外膜起搏器系统会带来并发症，例如由于生长和活动导致的导线扭曲，以及导线和囊袋并发症。对美国明尼苏达梅奥儿童医院（MN）2018 年至 2021 年期间的儿科无导线起搏器治疗进行了回顾性研究。记录了诊断、起搏理由、人口统计学、起搏阈值和设备的使用寿命。在体重 19-90kg 的患者中成功进行了 12 次无导线起搏器植入和 1 次取出。6 名患者通过颈内静脉进行 Micra 植入，无需手术切开。随访时间最长达 3 年，中位随访时间为 22 个月。未发生晚期并发症。无导线起搏器植入和早期取出在儿科患者中是可行的。
